BACKGROUND: Acute kidney injury (AKI) after cardiac surgery is associated with increased morbidity and mortality. METHODS: We assessed whether statin treatment is associated with a lower incidence of postoperative AKI in 2,104 consecutive patients who underwent coronary artery bypass graft or valve surgery at the Minneapolis Veterans Administration Medical Center. Acute kidney injury was defined as absolute increase greater than 0.3 mg/dL or relative increase greater than 50% in serum creatinine from baseline, within 48 hours after surgery or requiring postoperative hemodialysis per AKI network. Propensity scores were utilized to adjust for the differences between the statin and the no-statin treatment groups. All statins were converted to equivalent-dose simvastatin and divided at the median to construct high-dose (≥40 mg) and low-dose (<40 mg) statin groups. RESULTS: Of the 2,104 patients, 1,435 (68%) were taking statins (638 high-dose) and 495 (24%) developed AKI (25% high-dose vs 40% low-dose vs 35% no-statin; p = 0.014). Estimated preoperative glomerular filtration rate (p = 0.003), diabetes mellitus (p=0.02), valve surgery with or without coronary artery bypass graft (p = 0.024), cardiopulmonary bypass time (p = 0.001), and intraaortic balloon pump (p = 0.055) were independent predictors of AKI. After propensity adjustment statin treatment was not associated with postoperative AKI (odds ratio 0.79; 95% confidence interval 0.59 to 1.06; p = 0.11 for high-dose v. no-statin). After full adjustment for all independent predictors of AKI, the results did not change. Statins also had no effect on the incidence of postoperative hemodialysis (0.8% high-dose vs 1.9% low-dose vs 1% no-statin; p = 0.15). CONCLUSIONS: Statin treatment is not associated with a lower incidence of AKI after cardiac surgery. Copyright Â
BACKGROUND:Acute kidney injury (AKI) after cardiac surgery is associated with increased morbidity and mortality. METHODS: We assessed whether statin treatment is associated with a lower incidence of postoperative AKI in 2,104 consecutive patients who underwent coronary artery bypass graft or valve surgery at the Minneapolis Veterans Administration Medical Center. Acute kidney injury was defined as absolute increase greater than 0.3 mg/dL or relative increase greater than 50% in serum creatinine from baseline, within 48 hours after surgery or requiring postoperative hemodialysis per AKI network. Propensity scores were utilized to adjust for the differences between the statin and the no-statin treatment groups. All statins were converted to equivalent-dose simvastatin and divided at the median to construct high-dose (≥40 mg) and low-dose (<40 mg) statin groups. RESULTS: Of the 2,104 patients, 1,435 (68%) were taking statins (638 high-dose) and 495 (24%) developed AKI (25% high-dose vs 40% low-dose vs 35% no-statin; p = 0.014). Estimated preoperative glomerular filtration rate (p = 0.003), diabetes mellitus (p=0.02), valve surgery with or without coronary artery bypass graft (p = 0.024), cardiopulmonary bypass time (p = 0.001), and intraaortic balloon pump (p = 0.055) were independent predictors of AKI. After propensity adjustment statin treatment was not associated with postoperative AKI (odds ratio 0.79; 95% confidence interval 0.59 to 1.06; p = 0.11 for high-dose v. no-statin). After full adjustment for all independent predictors of AKI, the results did not change. Statins also had no effect on the incidence of postoperative hemodialysis (0.8% high-dose vs 1.9% low-dose vs 1% no-statin; p = 0.15). CONCLUSIONS: Statin treatment is not associated with a lower incidence of AKI after cardiac surgery. Copyright Â
Authors: Ann Coumbe; Ranjit John; Michael Kuskowski; Mehmet Agirbasli; Edward O McFalls; Selcuk Adabag Journal: BMC Cardiovasc Disord Date: 2011-10-20 Impact factor: 2.298
Authors: Kelvin C W Leung; Neesh Pannu; Zhi Tan; William A Ghali; Merril L Knudtson; Brenda R Hemmelgarn; Marcello Tonelli; Matthew T James Journal: Clin J Am Soc Nephrol Date: 2014-10-15 Impact factor: 8.237
Authors: An Verdoodt; Patrick M Honore; Rita Jacobs; Elisabeth De Waele; Viola Van Gorp; Jouke De Regt; Herbert D Spapen Journal: J Transl Int Med Date: 2018-03-28
Authors: J Bradley Layton; Abhijit V Kshirsagar; Ross J Simpson; Virginia Pate; Michele Jonsson Funk; Til Stürmer; M Alan Brookhart Journal: Am J Cardiol Date: 2012-12-28 Impact factor: 2.778
Authors: Lakhmir S Chawla; Richard L Amdur; Andrew D Shaw; Charles Faselis; Carlos E Palant; Paul L Kimmel Journal: Clin J Am Soc Nephrol Date: 2013-12-05 Impact factor: 8.237
Authors: Steven M Brunelli; Sushrut S Waikar; Brian T Bateman; Tara I Chang; Joyce Lii; Amit X Garg; Wolfgang C Winkelmayer; Niteesh K Choudhry Journal: Am J Med Date: 2012-10-09 Impact factor: 4.965
Authors: Amber O Molnar; Chirag R Parikh; Steven G Coca; Heather Thiessen-Philbrook; Jay L Koyner; Michael G Shlipak; Mary Lee Myers; Amit X Garg Journal: Ann Thorac Surg Date: 2014-04-12 Impact factor: 4.330